FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to a method for stratification of cancer patients for treating a tumor, and can be used in medicine. Invention enables stratifying a patient with breast cancer for adjuvant chemotherapy by the expression level of HER2, ESR1, PGR and Ki67 RNA transcripts.
EFFECT: invention enables predicting and predicting the success of the anticancer therapy and assessing the risk of a patient suffering breast cancer with respect to separate metastases.
25 cl, 21 dwg, 8 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING BREAST CANCER RECURRENT DURING ENDOCRINE TREATMENT | 2011 |
|
RU2654587C2 |
| SET OF REAGENTS FOR DETERMINING THE RISK OF RECURRENCE OF BREAST CANCER | 2017 |
|
RU2671557C1 |
| METHOD FOR DETERMINATION OF RISK OF BREAST ONCOLOGICAL DISEASES RECURRENCE | 2015 |
|
RU2626603C2 |
| METHOD FOR PREDICTING RISK OF BREAST CANCER PROGRESSION WITH UNDERLYING TAMOXIFEN TAKING INTO ACCOUNT EXPRESSION CHARACTERISTICS OF TUMOUR | 2023 |
|
RU2823488C1 |
| SET OF SYNTHETIC OLIGONUCLEOTIDES FOR DETERMINATION OF LEVELS OF GENE PDLIM4 EXPRESSION | 2015 |
|
RU2612139C1 |
| METHODS AND COMPOSITIONS RELATED TO FUSION OF ALPHA-LINOLENIC ACID FOR PURPOSES OF CANCER DETECTION AND TREATMENT | 2010 |
|
RU2562144C2 |
| DIAGNOSING AND TREATING BREAST CANCER | 2011 |
|
RU2550925C2 |
| METHOD OF DETERMINING PROBABILITY OF RECURRENT BREAST CANCER | 2014 |
|
RU2609199C2 |
| METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
| IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY | 2013 |
|
RU2644686C2 |
